ORAGENICS, INC. Increase (Decrease) in Accounts Receivable
ORAGENICS, INC. (OGEN) reported Increase (Decrease) in Accounts Receivable of $11.63 thousand for the 3-month period ending 2016-03-31, per its 10-Q filed 2016-05-16.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2016-05-16
- ORAGENICS, INC. increase (decrease) in accounts receivable for the quarter ending 2016-03-31 was $11.63K, a 16.63% decline year-over-year.
- ORAGENICS, INC. increase (decrease) in accounts receivable for the quarter ending 2015-12-31 was $1.75K.
- ORAGENICS, INC. increase (decrease) in accounts receivable for the quarter ending 2015-09-30 was -$7.43K, a 313.29% decline year-over-year.
- ORAGENICS, INC. increase (decrease) in accounts receivable for the quarter ending 2015-06-30 was -$2.76K.
- ORAGENICS, INC. increase (decrease) in accounts receivable for fiscal 2015 was $5.51K.
- ORAGENICS, INC. increase (decrease) in accounts receivable for fiscal 2014 was -$48.83K.
- ORAGENICS, INC. increase (decrease) in accounts receivable for fiscal 2013 was -$5.36K.
- ORAGENICS, INC. increase (decrease) in accounts receivable for fiscal 2012 was -$22.85K.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2016-03-31 | $11.63K 10-Q · filed 2016-05-16 | $13.38K derived: sum of 2 quarters · filed 2016-05-16 | $5.95K derived: sum of 3 quarters · filed 2016-05-16 | $3.19K derived: sum of 4 quarters · filed 2016-05-16 |
| 2015-12-31 | $1.75K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | -$5.68K derived: sum of 2 quarters · filed 2016-03-30 | -$8.45K derived: sum of 3 quarters · filed 2016-03-30 | $5.51K 10-K · filed 2016-03-30 |
| 2015-09-30 | -$7.43K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | -$10.19K derived: sum of 2 quarters · filed 2015-11-06 | $3.76K 10-Q · filed 2015-11-06 | -$6.94K derived: sum of 4 quarters · filed 2016-05-16 |
| 2015-06-30 | -$2.76K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | $11.19K 10-Q · filed 2015-08-07 | $489.00 derived: sum of 3 quarters · filed 2016-05-16 | $3.97K derived: sum of 4 quarters · filed 2016-05-16 |
| 2015-03-31 | $13.95K 10-Q · filed 2016-05-16 | $3.25K derived: sum of 2 quarters · filed 2016-05-16 | $6.74K derived: sum of 3 quarters · filed 2016-05-16 | -$13.32K derived: sum of 4 quarters · filed 2016-05-16 |
| 2014-12-31 | -$10.70K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | -$7.22K derived: sum of 2 quarters · filed 2016-03-30 | -$27.28K derived: sum of 3 quarters · filed 2016-03-30 | -$48.83K 10-K · filed 2016-03-30 |
| 2014-09-30 | $3.48K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | -$16.57K derived: sum of 2 quarters · filed 2015-11-06 | -$38.13K 10-Q · filed 2015-11-06 | -$32.57K derived: sum of 4 quarters · filed 2015-11-06 |
| 2014-06-30 | -$20.06K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | -$41.61K 10-Q · filed 2015-08-07 | -$36.05K derived: sum of 3 quarters · filed 2015-08-07 | -$26.79K derived: sum of 4 quarters · filed 2015-08-07 |
| 2014-03-31 | -$21.55K 10-Q · filed 2015-05-08 | -$15.99K derived: sum of 2 quarters · filed 2015-05-08 | -$6.73K derived: sum of 3 quarters · filed 2015-05-08 | -$12.55K derived: sum of 4 quarters · filed 2015-05-08 |
| 2013-12-31 | $5.56K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $14.82K derived: sum of 2 quarters · filed 2015-02-27 | $9.00K derived: sum of 3 quarters · filed 2015-02-27 | -$5.36K 10-K · filed 2015-02-27 |
| 2013-09-30 | $9.27K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-03 | $3.45K derived: sum of 2 quarters · filed 2014-11-03 | -$10.92K 10-Q · filed 2014-11-03 | -$13.50K derived: sum of 4 quarters · filed 2014-11-03 |
| 2013-06-30 | -$5.82K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | -$20.18K 10-Q · filed 2014-08-07 | -$22.77K derived: sum of 3 quarters · filed 2014-08-07 | $10.19K derived: sum of 4 quarters · filed 2014-08-07 |
| 2013-03-31 | -$14.37K 10-Q · filed 2014-05-09 | -$16.95K derived: sum of 2 quarters · filed 2014-05-09 | $16.01K derived: sum of 3 quarters · filed 2014-05-09 | -$7.88K derived: sum of 4 quarters · filed 2014-05-09 |
| 2012-12-31 | -$2.58K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $30.37K derived: sum of 2 quarters · filed 2014-02-28 | $6.48K derived: sum of 3 quarters · filed 2014-02-28 | -$22.85K 10-K · filed 2014-02-28 |
| 2012-09-30 | $32.96K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-25 | $9.06K derived: sum of 2 quarters · filed 2013-10-25 | -$20.27K 10-Q · filed 2013-10-25 | $28.05K derived: sum of 4 quarters · filed 2013-10-25 |
| 2012-06-30 | -$23.89K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-12 | -$53.22K 10-Q · filed 2013-08-12 | -$4.91K derived: sum of 3 quarters · filed 2013-08-12 | -$15.66K derived: sum of 4 quarters · filed 2013-08-12 |
| 2012-03-31 | -$29.33K 10-Q · filed 2013-05-15 | $18.98K derived: sum of 2 quarters · filed 2013-05-15 | $8.23K derived: sum of 3 quarters · filed 2013-05-15 | -$32.53K derived: sum of 4 quarters · filed 2013-05-15 |
| 2011-12-31 | $48.31K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-26 | $37.56K derived: sum of 2 quarters · filed 2013-03-26 | -$3.20K derived: sum of 3 quarters · filed 2013-03-26 | -$30.33K 10-K · filed 2013-03-26 |
| 2011-09-30 | -$10.76K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | -$51.52K derived: sum of 2 quarters · filed 2012-11-14 | -$78.64K 10-Q · filed 2012-11-14 | -$167.51K derived: sum of 4 quarters · filed 2012-11-14 |
| 2011-06-30 | -$40.76K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-10 | -$67.89K 10-Q · filed 2012-08-10 | -$156.76K derived: sum of 3 quarters · filed 2012-08-10 | -$118.45K derived: sum of 4 quarters · filed 2012-08-10 |
| 2011-03-31 | -$27.12K 10-Q · filed 2012-05-15 | -$115.99K derived: sum of 2 quarters · filed 2012-05-15 | -$77.69K derived: sum of 3 quarters · filed 2012-05-15 | |
| 2010-12-31 | -$88.87K derived: 10-K 12 month − 10-Q 9 month · filed 2012-04-16 | -$50.57K derived: sum of 2 quarters · filed 2012-04-16 | -$39.84K 10-K · filed 2012-04-16 | |
| 2010-09-30 | $38.30K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | $49.03K 10-Q · filed 2011-11-14 | ||
| 2010-06-30 | $10.73K 10-Q · filed 2011-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |